Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TAU PHOSPHORYLATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | TAU PHOSPHORYLATION |
| Key Genes/Proteins | APOE, BDNF, CDK5, GLUT4 |
| Related Diseases | ACETYLCHOLINE, ALZHEIMER'S DISEASE, AUTOPHAGY, CERAMIDE, DEMENTIA |
graph TD
TAU_PHOSPHORYLATION["TAU PHOSPHORYLATION"]
TAU_PHOSPHORYLATION -.biomarker for.-> Down_syndrome["Down syndrome"]
TAU_PHOSPHORYLATION -.biomarker for.-> Alzheimer_s_disease["Alzheimer's disease"]
Glucocorticoid_Receptor["Glucocorticoid Receptor"] -->|"regulates"| TAU_PHOSPHORYLATION
Amyloid__["Amyloid-beta"] -->|"activates"| TAU_PHOSPHORYLATION
phytochemicals["phytochemicals"] -->|"regulates"| TAU_PHOSPHORYLATION
p38_MAPK["p38 MAPK"] -->|"activates"| TAU_PHOSPHORYLATION
A_["Abeta"] -->|"activates"| TAU_PHOSPHORYLATION
NPTX2["NPTX2"] -->|"target for"| TAU_PHOSPHORYLATION
WIF1["WIF1"] -->|"target for"| TAU_PHOSPHORYLATION
AMYLOID["AMYLOID"] -->|"regulates"| TAU_PHOSPHORYLATION
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"expressed in"| TAU_PHOSPHORYLATION
AMYLOID___PLAQUES["AMYLOID-Beta PLAQUES"] -->|"expressed in"| TAU_PHOSPHORYLATION| Target | Relation | Type | Str |
|---|---|---|---|
| TAU | modulates | protein | 0.95 |
| Alzheimer's Disease | contributes_to | disease | 0.90 |
| Alzheimer's Disease | associated_with | disease | 0.90 |
| Neurodegeneration | contributes_to | process | 0.90 |
| Microtubule Instability | causes | phenotype | 0.90 |
| Alzheimer's Disease | drives | disease | 0.85 |
| Neuronal Degeneration | causes | process | 0.85 |
| Neurofibrillary Tangles | contributes_to | phenotype | 0.85 |
| Tau Aggregation | associated_with | process | 0.85 |
| Neurodegeneration | contributes_to | process | 0.85 |
| Alzheimer's Disease Neuropathology | contributes_to | mechanism | 0.80 |
| Alzheimer'S Disease | contributes_to | disease | 0.80 |
| Alzheimer's Disease | biomarker_for | disease | 0.80 |
| Redox Imbalance | causes | process | 0.75 |
| Down syndrome | biomarker_for | disease | 0.70 |
| SNAP25 | activates | gene | 0.70 |
| AUTOPHAGY | activates | phenotype | 0.70 |
| Alzheimer's disease | causes | disease | 0.70 |
| Alzheimer's disease | biomarker_for | disease | 0.70 |
| WNT PATHWAY | regulates | pathway | 0.65 |
| AUTOPHAGY | phosphorylates | phenotype | 0.65 |
| NEURONS | interacts_with | cell_type | 0.65 |
| MAPK | inhibits | gene | 0.65 |
| ACETYLCHOLINE | regulates | phenotype | 0.65 |
| EMPAGLIFLOZIN | associated_with | drug | 0.50 |
| GSK3 | regulates | concept | 0.50 |
| AMYLOID-β | regulates | concept | 0.50 |
| Infection | associated_with | disease | 0.50 |
| ORGANOIDS | associated_with | concept | 0.50 |
| Proteins | activates | protein | 0.50 |
| Nlrp3 Inflammasome | activates | pathway | 0.50 |
| Nlrp3 Inflammasome | causes | pathway | 0.50 |
| IPSC | inhibits | concept | 0.50 |
| GLIOSIS | associated_with | concept | 0.50 |
| IPSC | expressed_in | concept | 0.50 |
| INSULIN | activates | concept | 0.50 |
| AMYLOID-β | inhibits | concept | 0.50 |
| PREFRONTAL CORTEX | associated_with | brain_region | 0.50 |
| AMYGDALA | associated_with | brain_region | 0.50 |
| INSULIN SIGNALING | associated_with | pathway | 0.50 |
| LITHIUM | associated_with | drug | 0.50 |
| VISUAL CORTEX | associated_with | brain_region | 0.50 |
| Neuron | associated_with | cell_type | 0.50 |
| Microglia | associated_with | cell_type | 0.50 |
| DAPAGLIFLOZIN | associated_with | drug | 0.45 |
| ENTORHINAL CORTEX | associated_with | brain_region | 0.45 |
| WNT SIGNALING | associated_with | pathway | 0.45 |
| WNT PATHWAY | associated_with | pathway | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| NLRP3 INFLAMMASOME | associated_with | pathway | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SYK | regulates | gene | 0.95 |
| R406 | inhibits | drug | 0.95 |
| miR-219-5p | mediates | biomarker | 0.95 |
| Neddylation Inhibition | upregulates | mechanism | 0.92 |
| STING | activates | protein | 0.92 |
| Lumacaftor | inhibits | drug | 0.90 |
| BAY 61-3606 | inhibits | drug | 0.90 |
| Ceramide | promotes | compound | 0.90 |
| miR-219-5p | activates | biomarker | 0.90 |
| STING | upregulates | protein | 0.90 |
| ceramide | promotes | compound | 0.90 |
| AMPK | promotes | protein | 0.90 |
| LARS2 | inhibits | gene | 0.90 |
| Testosterone | inhibits | compound | 0.90 |
| TBK1 | upstream_of | protein | 0.88 |
| PKR | mediates | protein | 0.88 |
| Brain Cholesterol Accumulation | promotes | phenotype | 0.85 |
| TYROBP | regulates | protein | 0.85 |
| GSK-3β | involved_in | enzyme | 0.85 |
| LRRK2 | associated_with | protein | 0.85 |
| Amyloid-β | associated_with | compound | 0.85 |
| NLRP3 Inflammasome | mediates | pathway | 0.85 |
| MAPK14 | mediates | protein | 0.85 |
| Lipopolysaccharide | associated_with | compound | 0.85 |
| PP2A | downregulates | protein | 0.85 |
| TTBK1 | involved_in | enzyme | 0.85 |
| TBK1 | mediates | protein | 0.85 |
| GMPR1 | associated_with | protein | 0.85 |
| Chronic Sleep Deprivation | causes | process | 0.85 |
| GSK3B | mediates | protein | 0.85 |
| MIR-125B | upregulates | gene | 0.80 |
| amyloid-beta | promotes | protein | 0.80 |
| BDNF | disrupts | gene | 0.80 |
| MIR-132 | inhibits | gene | 0.80 |
| Abeta | contributes_to | compound | 0.80 |
| MIR-212 | inhibits | gene | 0.80 |
| neurons | activates | cell_type | 0.80 |
| Rg1 | inhibits | compound | 0.80 |
| Hyperbaric Oxygen Therapy | inhibits | drug | 0.80 |
| GSK3B | upregulates | protein | 0.80 |
| NF-κB | modulates | protein | 0.80 |
| GMPR | modulates | gene | 0.80 |
| Oxidative Stress | upregulates | process | 0.80 |
| miR-206-3p | associated_with | compound | 0.75 |
| Glucocorticoid Receptor | regulates | receptor | 0.75 |
| autophagy | regulates | process | 0.70 |
| microglia | activates | cell_type | 0.70 |
| Aβ | activates | protein | 0.70 |
| p38 MAPK | activates | pathway | 0.70 |
| phytochemicals | regulates | drug | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TAU PHOSPHORYLATION in their description or question text
No additional research found